Todd Lanman, MD, and Joel Beckett, MD, have performed the first post-FDA-approval case using the Synergy Disc.
They completed a three-level cervical disc replacement procedure five weeks after the device received premarket approval for single-level use from the C3-C7 vertebrae, according to an April 8 news release.
The motion-preserving artificial disc is designed to maintain spinal alignment while allowing controlled movement, offering an alternative to fusion procedures.
The case marks an early step in clinical adoption of the device, with broader use expected as surgeons gain experience with the technology, the release said.
The surgery was completed at Advanced Surgery Center of Beverly Hills (Calif.).
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
